Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

dulaglutide

dulaglutide
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Trulicity SOLUTION, SUBCUTANEOUS 0.75 mg/0.5 mL, 1.5 mg/0.5 mL      
Comments:

Trulicity is approved for sample use in HH Endocrinology and Diabetes Clinics.

Trulicity medication guide

This is a GLP-1 receptor agonist used to treat diabetes type-2, dosed subcutaneously once weekly.  Non-formulary, not stocked, defer to after discharge.  Inpatients may use their own supply if judged necessary.

REMS (Trulicity): View FDA REMS Info

Last updated: Jan. 17, 2023






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved